Πρωτεύουσες καρτέλες
Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.
Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited..
J Gastrointestin Liver Dis. 29(2), 270-271.
(2020).
Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020).
Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease..
Aliment Pharmacol Ther. 51(2), 313-314.
(2020).
Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma..
Aliment Pharmacol Ther. 51(11), 1215-1216.
(2020).
Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap..
J Clin Gastroenterol. 54(2), 200-201.
(2020).
Response to letter to the editor of Carcinogenesis by Li et al., 2020..
Carcinogenesis. 41(4), 539-540.
(2020).
National consensus on infection: the next-day challenge..
Ann Gastroenterol. 33(3), 324-325.
(2020).
Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis..
Metabolism. 154203.
(2020).
Alzheimer's disease and gastrointestinal microbiota; impact of infection involvement..
Int J Neurosci. 1-13.
(2020).
Nonalcoholic fatty liver disease in males with low testosterone concentrations..
Diabetes Metab Syndr. 14(5), 1571-1577.
(2020).
Potential impact of Helicobacter pylori-related Galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis..
Dig Liver Dis. 52(1), 121-123.
(2020).
Rodent models of obesity..
Minerva Endocrinol. 45(3), 243-263.
(2020).
Helicobacter pylori infection as a potential risk factor for multiple sclerosis..
Med Hypotheses. 143, 110135.
(2020).
Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing..
Med Hypotheses. 110379.
(2020).
Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis..
Ann Hepatol. 19(5), 579-580.
(2020).
Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection..
Int J Clin Pract. e13737.
(2020).
Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement..
Metabolism. 96, 66-82.
(2019).
Σελίδες
- « πρώτη
- ‹ προηγούμενη
- …
- 3
- 4
- 5
- 6
- 7
- …
- επόμενη ›
- τελευταία »